Use of multiple metrics to assess antibiotic use in Italian children's hospitals.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 02 2021
11 02 2021
Historique:
received:
17
09
2020
accepted:
25
01
2021
entrez:
12
2
2021
pubmed:
13
2
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Quantification of antibiotic utilization is an essential component of antibiotic stewardship programs. In this multicentric study, we used different metrics to evaluate inpatient antibiotic use in children. The study objectives were to describe point prevalence of antibiotic use by indication and patient characteristics, to evaluate DOTs, LOTs and PDDs, and to compare PDDs to DDDs, which assume average maintenance dose per day in adults. All children hospitalized on the days of the study were included. Trained personnel collected demographic and clinical data from patients' clinical records. We recorded information about antibiotics administered on the date of data collection, and in the previous 30 days of hospitalization. Of 810 patients, 380 (46.9%; CI 95%: 43.4-50.4) received one or more antibiotics; prevalence of use was 27.0% for prophylaxis (219/810), and 20.7% (168/810) for treatment. Overall, 587 drugs were issued to the 380 patients receiving antibiotics (1.5 antibiotic per patient). When considering treatments, DOT and LOT per 100 patient-days were 30.5 and 19.1, respectively, resulting in a DOT/LOT ratio of 1.6. PDDs increased with age and approached DDDs only in children aged ≥ 10 years; the ratio between PDDs estimated in children aged ≥ 10 years and in 0-11 month-old infants ranged from 2 for sulfamethoxazole and trimethoprim, to 25 for meropenem. Our results confirm that DOT, LOT and PDD are better alternatives to DDD in children.
Identifiants
pubmed: 33574450
doi: 10.1038/s41598-021-83026-1
pii: 10.1038/s41598-021-83026-1
pmc: PMC7878731
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3543Références
Can J Infect Dis. 2004 Jan;15(1):29-35
pubmed: 18159441
Antimicrob Resist Infect Control. 2013 Nov 18;2:31
pubmed: 24237856
BMJ Open. 2016 Nov 3;6(11):e012675
pubmed: 27810974
BMJ. 2007 Sep 1;335(7617):429
pubmed: 17656505
Circulation. 2000 Jun 27;101(25):2916-21
pubmed: 10869263
Eur J Pediatr. 2018 Aug;177(8):1271-1278
pubmed: 29948254
Pediatr Infect Dis J. 2013 Jun;32(6):e242-53
pubmed: 23838740
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
J Antimicrob Chemother. 2010 Oct;65(10):2247-52
pubmed: 20713405
J Antimicrob Chemother. 2016 Apr;71(4):1106-17
pubmed: 26747104
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):1-6
pubmed: 23884866
J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi50-vi58
pubmed: 29878222
Clin Microbiol Rev. 2013 Apr;26(2):289-307
pubmed: 23554418
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1301-3
pubmed: 20556467
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Infection. 2009 Aug;37(4):349-52
pubmed: 19277464